Review from host and guest approach to new frontiers nutraceuticals in the era of COVID-19
Matteo Micucci,
Silvia Gioacchini,
Melissa Baggieri,
Raoul Fioravanti,
Paola Bucci,
Roberto Giuseppetti,
Srwa S. Saleem,
Sazan Q. Maulud,
Fuad O. Abdullah,
Badr Q. Ismael,
Jivan Q. Ahmed,
Emilio D'Ugo,
Antonella Marchi,
Udodinma Jude Okeke,
Fabio Magurano
Affiliations
Matteo Micucci
Department of Biomolecular Sciences, Università degli Studi di Urbino ''Carlo Bo'', Piazza Rinascimento, 6, 61029 Urbino PU, Italy
Silvia Gioacchini
Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy
Melissa Baggieri
Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy
Raoul Fioravanti
Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy
Paola Bucci
Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy
Roberto Giuseppetti
Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy
Srwa S. Saleem
Department of Biology, College of Education, Salahaddin University-Erbil, Erbil, Iraq
Sazan Q. Maulud
Department of Biology, College of Education, Salahaddin University-Erbil, Erbil, Iraq
Fuad O. Abdullah
Department of Chemistry, College of Science, Salahaddin University-Erbil, Erbil, Iraq; Department of Pharmacognosy, Faculty of Pharmacy, Tishk International University, Erbil, Iraq
Badr Q. Ismael
Department of Biology, College of Science, Salahaddin University-Erbil, Erbil, Iraq
Jivan Q. Ahmed
Department of Pathology and Microbiology, University of Duhok, Kurdistan Region, Iraq
Emilio D'Ugo
Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy
Antonella Marchi
Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy
Udodinma Jude Okeke
Department of Biomolecular Sciences, Università degli Studi di Urbino ''Carlo Bo'', Piazza Rinascimento, 6, 61029 Urbino PU, Italy
Fabio Magurano
Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy; Corresponding author at: Department of Infectious Diseases, ISS, Viale Regina Elena 299 00161 Rome.
COVID-19 continues to claim victims in the world, especially among elderly subjects and people suffering from chronic-degenerative pathologies, like cardiovascular diseases. Several vaccines and drugs have been developed to mitigate the infection spread and its deleterious consequences. However, the emergence of new variants requires the identification of solutions to deal with the challenging mutations. In this context, the investigation of phytocomplexes and related compounds used in folk medicine and culinary purposes may lead to unfold nutraceuticals endowed with antiviral, and cardioprotective properties. We have described several vegetal extracts and secondary metabolites that hit the most important viral and host targets and bind them. The connection between SARS-CoV-2 and cardiovascular diseases were also outlined, as well as phytocomplexes with potentials for their mitigation. The review provides both an entry point for new researchers in this area, and a comprehensive overview for further investigation of the natural products presented.